<DOC>
	<DOC>NCT01612819</DOC>
	<brief_summary>Registry of cilotax stent(Dual drug eluting stent) implantation for CAD patients</brief_summary>
	<brief_title>DXR Stent(Previous Cilotax) Implantation Registry</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients with significant coronary artery disease and receiving Cilotax (dual drug eluting stent) The patient or guardian agrees to the study protocol and the schedule of clinical followup, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site Patients with a mixture of other DESs Terminal illness with life expectancy &lt;1 year Patients presented with cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>